Pharmaceuticals
Company Overview of Sopherion Therapeutics, LLC
Company Overview
Sopherion Therapeutics, LLC, a biopharmaceutical company, together with its subsidiary, Sopherion Therapeutics Canada, focuses on the development and commercialization of anti-cancer therapies for patients suffering with advanced cancer in North America. Its lead product candidate, Myocet, is in Phase III development stage for the first-line treatment of metastatic breast cancer. Sopherion Therapeutics, LLC was founded in 2001 and is based in Princeton, New Jersey with additional offices in Cheshire, Connecticut and Estero, Florida; and an operating subsidiary in Toronto, Canada.
104 Carnegie Center
Suite 200
Princeton, NJ 08540
United States
Founded in 2001
Key Executives for Sopherion Therapeutics, LLC
Similar Private Companies By Industry
| Company Name | Region |
| Abbey Pharmaceuticals, Inc. | United States |
| Health & Nutrition Systems International, Inc. | United States |
| Anagen Therapeutics, Inc. | United States |
| Lifecycle Pharma Inc. | United States |
| Silamed, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Louisville, KY | AstraZenecaPosted: May 21
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact Sopherion Therapeutics, LLC, please visit www.sopherion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
